Superworth

Medtronic EV/EBIT MDT

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2015.

Today, Nov 3, 2026
21.5×
10-year median
21.8×
Against its 10-year history
44th
percentile: 0 is its lowest day, 100 its highest
10-year range
17.8× to 52.1×
Peer median
22.9×

Medtronic's EV/EBIT is 21.5× as of Nov 3, 2026.

That is below its ten-year median of 21.8×, close to the middle of its last ten years.

Over that time it ranged from 17.8× in May 2026 to 52.1× in Apr 2021.

The median for 7 medical device stocks of a similar size is 22.9×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far21.5×17.8×23.2×
202522.0×19.8×23.7×
202420.6×20.2×23.8×
202321.3×18.4×23.3×
202218.7×18.3×25.5×
202124.4×23.8×52.1×
202042.8×18.1×42.8×
201925.6×19.8×25.7×
201821.0×18.3×22.7×
201720.0×20.0×25.1×
201620.7×20.7×29.0×
201527.0×26.8×27.2×

Against its peers

Companies in Medical - Devices nearest Medtronic's size, closest first, today.

CompanyEV/EBIT
MDTMedtronic21.5×
SYKStryker22.9×
ABTAbbott Laboratories29.7×
BSXBoston Scientific17.7×
EWEdwards Lifesciences24.7×
GEHCGE HealthCare Technologies14.9×
DXCMDexCom25.8×
ZBHZimmer Biomet21.3×
Peer median22.9×

Where Medtronic ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Medtronic

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.